Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Hims & Hers Health (HIMS)

Hims & Hers completes Eucalyptus acquisition and amends its credit agreement

Neutral Impact 3 of 5 m&a Written later

Hims & Hers completed its acquisition of Eucalyptus, an Australia-based consumer health platform, and announced it on June 2, 2026. Under Amendment No. 3 to its revolving credit agreement, dated May 29, 2026, the company received a grace period to comply with covenants and representations affected by the acquisition. The filing does not disclose the purchase price.

Key points

  • Amendment No. 3 is dated May 29, 2026; JPMorgan Chase Bank, N.A. is administrative and collateral agent.
  • The amendment provides a grace period on credit agreement covenants and representations tied to the Eucalyptus acquisition, sets joinder obligations for material foreign subsidiaries, and increases downstream investment capacity in non-loan
  • The filing states that interest provisions, fees, covenants and events of default were otherwise unchanged.
  • Eucalyptus has more than 850,000 customers as of May 2026, and the company reiterated long-term targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030.

The filing

CompanyHims & Hers Health (HIMS)
Form8-K, current report
Filed with the SECJun 2, 2026, 6:02 AM ET
Accession number0001773751-26-000091

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.